Yossef S. Levy

1.3k total citations
15 papers, 938 citations indexed

About

Yossef S. Levy is a scholar working on Genetics, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Yossef S. Levy has authored 15 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Molecular Biology. Recurrent topics in Yossef S. Levy's work include Nerve injury and regeneration (9 papers), Mesenchymal stem cell research (8 papers) and Pluripotent Stem Cells Research (6 papers). Yossef S. Levy is often cited by papers focused on Nerve injury and regeneration (9 papers), Mesenchymal stem cell research (8 papers) and Pluripotent Stem Cells Research (6 papers). Yossef S. Levy collaborates with scholars based in Israel and United States. Yossef S. Levy's co-authors include Eldad Melamed, Daniel Offen, Yael Barhum, Shlomo Bulvik, Yaël Gothelf, Panayiota Petrou, Adi Vaknin‐Dembinsky, Tamir Ben‐Hur, Zohar Argov and Dimitrios Karussis and has published in prestigious journals such as Neurology, Neuroscience Letters and JAMA Neurology.

In The Last Decade

Yossef S. Levy

15 papers receiving 915 citations

Peers

Countries citing papers authored by Yossef S. Levy

Since Specialization

Citations

This map shows the geographic impact of Yossef S. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yossef S. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yossef S. Levy more than expected).

Fields of papers citing papers by Yossef S. Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yossef S. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yossef S. Levy. The network helps show where Yossef S. Levy may publish in the future.

Co-authorship network of co-authors of Yossef S. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Yossef S. Levy. A scholar is included among the top collaborators of Yossef S. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yossef S. Levy. Yossef S. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis 2022 ·Multiple Sclerosis Journal ·Jeffrey A. Cohen, Fred Lublin, Christopher Lock, Daniel Pelletier, Tanuja Chitnis, Mandeep R. Mehra, Yaël Gothelf, Revital Aricha, Stacy Lindborg, (unknown), Yossef S. Levy, (unknown), R. Kern	19
2	NurOwn, phase 2, randomized, clinical trial in patients with ALS 2019 ·Neurology ·James D. Berry, Merit Cudkowicz, Anthony J. Windebank, Nathan P. Staff, Margaret Owegi, Katherine L. Nicholson, Diane McKenna‐Yasek, Yossef S. Levy, Natalie Abramov, Haggai Kaspi, Mandeep R. Mehra, Revital Aricha, Yaël Gothelf, Robert H. Brown	100
3	MODULATION OF CSF miRNAs IN ALS PHASE 2 STUDY PARTICIPANTS TREATED WITH MSC-NTF CELLS (NUROWN®) (S25.005) 2018 ·Neurology ·Revital Aricha, Haggai Kaspi, Merit Cudkowicz, James D. Berry, Anthony J. Windebank, Nathan P. Staff, Margaret Owegi, Yossef S. Levy, (unknown), Robert H. Brown, Yaël Gothelf, R. Kern	1
4	Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis 2016 ·JAMA Neurology ·Panayiota Petrou, Yaël Gothelf, Zohar Argov, Marc Gotkine, Yossef S. Levy, Ibrahim Kassis, Adi Vaknin‐Dembinsky, Tamir Ben‐Hur, Daniel Offen, Oded Abramsky, Eldad Melamed, Dimitrios Karussis	233
5	Autologous Transplantation of Mesenchymal Stem Cells Secreting Neurotrophic Factors (Nurown™) In ALS: Results of a Phase 2 Clinical Trial (P2.059) 2015 ·Neurology ·Panayiota Petrou, Marc Gotkine, Yaël Gothelf, Yossef S. Levy, Daniel Offen, Adi Vaknin‐Dembinsky, Zohar Argov, Tamir Ben‐Hur, Eldad Melamed, Dimitrios Karussis	2
6	Update on clinical trials with autologous bone marrow-derived mesenchymal stem cells secreting neurotrophic factors (MSC-NTF) in patients with amyotrophic lateral sclerosis (ALS) 2015 ·Cytotherapy ·Yaël Gothelf, (unknown), Marc Gotkine, Adi Vaknin‐Dembinsky, Yossef S. Levy, (unknown), Tamir Ben‐Hur, Eldad Melamed, (unknown)	3
7	Protective Effects of Neurotrophic Factor–Secreting Cells in a 6-OHDA Rat Model of Parkinson Disease 2009 ·Stem Cells and Development ·Ofer Sadan, (unknown), Yael Barhum, Yossef S. Levy, (unknown), (unknown), (unknown), Shlomo Bulvik, Noam Shemesh, Dana Krepel, Yoram Cohen, Eldad Melamed, Daniel Offen	127
8	Induction of Adult Human Bone Marrow Mesenchymal Stromal Cells into Functional Astrocyte-Like Cells: Potential for Restorative Treatment in Parkinson’s Disease 2009 ·Journal of Molecular Neuroscience ·(unknown), Yael Barhum, Yossef S. Levy, (unknown), Shlomo Bulvik, Eldad Melamed, Daniel Offen	71
9	Dopaminergic differentiation of human mesenchymal stem cells—Utilization of bioassay for tyrosine hydroxylase expression 2007 ·Neuroscience Letters ·(unknown), Tali Ben‐Zur, Yael Barhum, Yossef S. Levy, (unknown), (unknown), Shlomo Bulvik, Eldad Melamed, Daniel Offen	47
10	Human Mesenchymal Stem Cells Express Neural Genes, Suggesting a Neural Predisposition 2006 ·Stem Cells and Development ·(unknown), Yossef S. Levy, Tali Ben‐Zur, (unknown), (unknown), (unknown), (unknown), (unknown), Yael Barhum, Shlomo Bulvik, Eldad Melamed, Daniel Offen	135
11	Adult stem cells for neuronal repair. 2006 ·PubMed ·Ran Barzilay, Yossef S. Levy, Eldad Melamed, Daniel Offen	15
12	Therapeutic Potential of Neurotrophic Factors in Neurodegenerative Diseases 2005 ·BioDrugs ·Yossef S. Levy, Yossi Gilgun‐Sherki, Eldad Melamed, Daniel Offen	68
13	Embryonic and Adult Stem Cells As a Source for Cell Therapy in Parkinson's Disease 2004 ·Journal of Molecular Neuroscience ·Yossef S. Levy, (unknown), Eldad Melamed, Daniel Offen	37
14	Induction of Neuron-Specific Enolase Promoter and Neuronal Markers in Differentiated Mouse Bone Marrow Stromal Cells 2003 ·Journal of Molecular Neuroscience ·Yossef S. Levy, Doron Merims, (unknown), Yael Barhum, Eldad Melamed, Daniel Offen	49
15	Hemin-induced apoptosis in PC12 and neuroblastoma cells: Implications for local neuronal death associated with intracerebral hemorrhage 2002 ·Neurotoxicity Research ·Yossef S. Levy, Jonathan Y. Streifler, (unknown), Eldad Melamed, Daniel Offen	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact